ICG 2013 - 2nd International Conference on Genomics in the Americas

ICG Americas-II ? The 2nd International Conference on Genomics in the Americas
September 12-13, 2013
Sacramento, CA
The 2nd International Conference on Genomics in the Americas will bring together the unique strengths of two world-class institutions ? BGI and University of California, Davis ? to provide a powerful platform to share ground-breaking research in basic and applied genomics and to advance new approaches to sequencing and bioinformatics.
Scheduled for September 12 - 13, 2013 in Sacramento, CA, ICG Americas-II is modeled after BGI’s International Conferences on Genomics held annually since 2006 in China, which is regarded as one of the top scientific gatherings that features recent developments in genome sciences. The conference is uniquely formatted to maximize opportunities to interact directly with other genomics industry luminaries, scientific thought leaders, key decision makers, top pharmaceutical executives, and influential policy makers.
Highlights of ICG Americas-II include:
Prestigious gathering of global thought leaders devoted to the latest developments in human, plant, microbial, and animal genome sciences
Pre-conference training programs offered by the UC Davis Genome Center
Pre-conference microbial genomics meeting hosted by the FDA
A full-service dinner that brings Napa Valley to Sacramento with wine tasting, demonstration and live entertainment, attended exclusively by conference speakers, luminaries and other conference attendees
Proximity to multiple international life sciences companies in the Bay Area
Access to multiple national historical sites and museums in Sacramento and to world-class outdoor recreation in Lake Tahoe
Register before May 31, 2013, and save up to 200 USD!
Register during July 31, 2013 , and save up to 100 USD!
Speakers:
Dr. Leroy Hood - President, Institute for Systems Biology
Dr. Bahija Jallal - Executive Vice President, AstraZeneca & Head, MedImmune?
Dr. David Bergvinson - Deputy Director, Agricultural Development, Bill & Melinda Gates Foundation
Dr. Richard Roberts - Chief Scientific Officer, New England Biolabs?
Dr. Huanming Yang - Chairman & Professor, BGI
Dr. Jun Wang - Executive Director, BGI
Dr. Linda Katehi - Chancellor, UC Davis
Dr. Harris Lewin - Vice Chancellor of Research, UC Davis
Dr. James Watters - Head of Applied Genomics, Sanofi Oncology
Dr. Fred Dubee - Special Advisor, United Nations Global Compact
Dr. Oscar Puig - Biomarker & Experimental Medicine Leader in Oncology, Translational Clinical Research Center, Roche
Dr. John M. Maris - Director, Center for Childhood Cancer Research, CHOP; Professor, UPenn
Dr. Luis G. Carvajal-Carmona - Assistant Professor, UC Davis
Dr. Robert Hills - Senior Scientist, Johnson and Johnson
Dr. Brett Tyler - Professor & Director of Center for Genome Research & Biocomputing, Oregon State University
Dr. Rasmus Nielsen - Professor, University of Copenhagen & UC Berkeley
Dr. Pamela Ronald - Professor, Department of Plant Pathology & the Genome Center, UC Davis
Mr. Yingrui Li - Chief Executive Officer, BGI Americas
Dr. Lihua Yu - Director of Bioinformatics, H3 Biomedicine
Dr. Robert Sandrock - Principal Scientist, Amgen, Inc.
Dr. Allen Sessions - Team Leader, Bayer Crop Science
And many more